{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:34:18Z","timestamp":1767339258628,"version":"build-2065373602"},"reference-count":80,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research Foundation Postdoctoral Fellowship Grant","award":["50632","138392"],"award-info":[{"award-number":["50632","138392"]}]},{"name":"National Research Foundation Thuthuka","award":["50632","138392"],"award-info":[{"award-number":["50632","138392"]}]},{"name":"South African Medical Research Council (SAMRC) Biomedical and Research Innovation Platform (BRIP)","award":["50632","138392"],"award-info":[{"award-number":["50632","138392"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Computation"],"abstract":"<jats:p>Cancer remains a major challenge in the field of medicine, necessitating innovative therapeutic strategies. Mitogen-activated protein kinase (MAPK) signaling pathways, particularly Extracellular Signal-Regulated Kinase 1 and 2 (ERK1\/2), play pivotal roles in cancer pathogenesis. Recently, ERK5 (also known as MAPK7) has emerged as an attractive target due to its compensatory role in cancer progression upon termination of ERK1 signaling. This study explores the potential of Compound 22ac, a novel small molecule inhibitor, to simultaneously target both ERK1 and ERK5 in cancer cells. Using molecular dynamics simulations, we investigate the binding affinity, conformational dynamics, and stability of Compound 22ac when interacting with ERK1 and ERK5. Our results indicate that Compound 22ac forms strong interactions with key residues in the ATP-binding pocket of both ERK1 and ERK5, effectively inhibiting their catalytic activity. Furthermore, the simulations reveal subtle differences in the binding modes of Compound 22ac within the two kinases, shedding light on the dual inhibitory mechanism. This research not only elucidates a structural mechanism of action of Compound 22ac, but also highlights its potential as a promising therapeutic agent for cancer treatment. The dual inhibition of ERK1 and ERK5 by Compound 22ac offers a novel approach to disrupting the MAPK signaling cascade, thereby hindering cancer progression. These findings may contribute to the development of targeted therapies that could improve the prognosis for cancer patients.<\/jats:p>","DOI":"10.3390\/computation12030045","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T06:07:53Z","timestamp":1709273273000},"page":"45","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Unraveling the Dual Inhibitory Mechanism of Compound 22ac: A Molecular Dynamics Investigation into ERK1 and ERK5 Inhibition in Cancer"],"prefix":"10.3390","volume":"12","author":[{"given":"Elliasu Y.","family":"Salifu","sequence":"first","affiliation":[{"name":"Biomedical Research and Innovation Platform (BRIP), South African Medical Research Council (SAMRC), Tygerberg 7505, South Africa"},{"name":"School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban 4001, South Africa"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0315-2619","authenticated-orcid":false,"given":"Mbuso A.","family":"Faya","sequence":"additional","affiliation":[{"name":"School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban 4001, South Africa"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1871-8048","authenticated-orcid":false,"given":"James","family":"Abugri","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Forensic Sciences, School of Chemical and Biochemical Sciences, C. K. Tedam University of Science and Technology, Navrongo P.O. Box 24, Ghana"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5850-6782","authenticated-orcid":false,"given":"Pritika","family":"Ramharack","sequence":"additional","affiliation":[{"name":"Biomedical Research and Innovation Platform (BRIP), South African Medical Research Council (SAMRC), Tygerberg 7505, South Africa"},{"name":"School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban 4001, South Africa"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"key":"ref_1","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis (Review)","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/MCB.19.4.2435","article-title":"Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers","volume":"19","author":"Schaeffer","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kumar, S., Principe, D.R., Singh, S.K., Viswakarma, N., Sondarva, G., Rana, B., and Rana, A. (2020). Mitogen-activated protein kinase inhibitors and T-cell-dependent immunotherapy in cancer. Pharmaceuticals, 13.","DOI":"10.3390\/ph13010009"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Gaestel, M. (2016). MAPK-activated protein kinases (MKs): Novel insights and challenges. Front. Cell Dev. Biol., 3.","DOI":"10.3389\/fcell.2015.00088"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1242\/jcs.01481","article-title":"MAP kinases and cell migration","volume":"117","author":"Huang","year":"2004","journal-title":"J. Cell Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-60761-795-2_1","article-title":"The MAP Kinase Signaling Cascades: A System of Hundreds of Components Regulates a Diverse Array of Physiological Functions","volume":"661","author":"Keshet","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.smim.2014.02.009","article-title":"TNF and MAP kinase signalling pathways","volume":"26","author":"Sabio","year":"2014","journal-title":"Semin. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbamcr.2010.12.012","article-title":"The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation","volume":"1813","author":"Plotnikov","year":"2011","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Eblen, S.T. (2018). Extracellular-Regulated Kinases: Signaling from Ras to ERK Substrates to Control Biological Outcomes, Elsevier. [1st ed.].","DOI":"10.1016\/bs.acr.2018.02.004"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbamcr.2018.09.002","article-title":"Dual-specificity MAP kinase phosphatases in health and disease","volume":"1866","author":"Seternes","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J. Recept. Signal Transduct."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0074-7742(04)59008-6","article-title":"Mitogen-activated protein kinase signaling","volume":"59","author":"Kyosseva","year":"2004","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Soares-Silva, M., Diniz, F.F., Gomes, G.N., and Bahia, D. (2016). The mitogen-activated protein kinase (MAPK) pathway: Role in immune evasion by trypanosomatids. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00183"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Autodock vina: Improving the speed and accuracy of docking","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1158\/1535-7163.MCT-19-0505","article-title":"Dual-mechanism ERK1\/2 inhibitors exploit a distinct binding mode to block phosphorylation and nuclear accumulation of ERK1\/2","volume":"19","author":"Kidger","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"43344","DOI":"10.1074\/jbc.M207573200","article-title":"ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression","volume":"277","author":"Sohn","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1038\/sj.onc.1204541","article-title":"Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion","volume":"20","author":"Krueger","year":"2001","journal-title":"Oncogene"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1158\/0008-5472.CAN-05-3676","article-title":"The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma","volume":"66","author":"Hickson","year":"2006","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1038\/sj.onc.1207556","article-title":"Mitogen-activated protein kinases in apoptosis regulation","volume":"23","author":"Wada","year":"2004","journal-title":"Oncogene"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s000180050369","article-title":"The stress-activated protein kinase pathways","volume":"55","author":"Tibbles","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/35065000","article-title":"Mammalian MAP kinase signalling cascades","volume":"410","author":"Chang","year":"2001","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","article-title":"The MAPK signaling Cascade","volume":"9","author":"Seger","year":"1995","journal-title":"FASEB J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s41467-020-15031-3","article-title":"Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors","volume":"11","author":"Lochhead","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"11551","DOI":"10.1038\/ncomms11551","article-title":"ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1\/2 abrogation","volume":"7","author":"Taniguchi","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.cr.7290105","article-title":"MAPK signal pathways in the regulation of cell proliferation in mammalian cells","volume":"12","author":"Zhang","year":"2002","journal-title":"Cell Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/BJ20131571","article-title":"Small-molecule inhibitors of ERK-mediated immediate early gene expression and proliferation of melanoma cells expressing mutated BRaf","volume":"467","author":"Samadani","year":"2015","journal-title":"Biochem. J."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lu, N., and Malemud, C.J. (2019). Extracellular signal-regulated kinase: A regulator of cell growth, inflammation, chondrocyte and bone cell receptor-mediated gene expression. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153792"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbcan.2011.10.002","article-title":"MEK5\/ERK5 pathway: The first fifteen years","volume":"1825","author":"Drew","year":"2012","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1021\/acs.jmedchem.9b01896","article-title":"Discovery of a Novel Dual-Target Inhibitor of ERK1 and ERK5 That Induces Regulated Cell Death to Overcome Compensatory Mechanism in Specific Tumor Types","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/27234","article-title":"Bmk1\/Erk5 is required for cell proliferation induced byepidermalgrowth factor","volume":"395","author":"Kato","year":"1998","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1074\/jbc.M009764200","article-title":"ERK5 and ERK2 Cooperate to Regulate NF-\u03baB and Cell Transformation","volume":"276","author":"Pearson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/sj.embor.7400755","article-title":"MAPK signalling: ERK5 versus ERK1\/2","volume":"7","author":"Nishimoto","year":"2006","journal-title":"EMBO Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1158\/2326-6066.CIR-15-0241","article-title":"Mutant KRAS conversion of conventional T cells into regulatory T cells","volume":"4","author":"Zdanov","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canlet.2017.01.034","article-title":"Oncogenic signaling of MEK5-ERK5","volume":"392","author":"Hoang","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"20753","DOI":"10.18632\/oncotarget.8012","article-title":"Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: A combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors","volume":"7","author":"Kopecka","year":"2016","journal-title":"Oncotarget"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"53518","DOI":"10.18632\/oncotarget.18591","article-title":"SHP2 negatively regulates HLA-ABC and PD-L1 expression via STAT1 phosphorylation in prostate cancer cells","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.18632\/oncotarget.2731","article-title":"Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma","volume":"6","author":"Salaroglio","year":"2015","journal-title":"Oncotarget"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00262-017-2005-z","article-title":"KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma","volume":"66","author":"Chen","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1158\/0008-5472.CAN-18-0152","article-title":"Inhibition of RSPO-LGR4 facilitates checkpoint blockade therapy by switching macrophage polarization","volume":"78","author":"Tan","year":"2018","journal-title":"Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.2147\/OTT.S105245","article-title":"The roles of serum CXCL16 in circulating Tregs and gastrointestinal stromal tumor cells","volume":"9","author":"Xing","year":"2016","journal-title":"Onco. Targets. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.bbadis.2018.03.002","article-title":"PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras\/Erk\/EMT activation","volume":"1864","author":"Qiu","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"27252","DOI":"10.18632\/oncotarget.4583","article-title":"TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression","volume":"6","author":"Ho","year":"2015","journal-title":"Oncotarget"},{"key":"ref_44","first-page":"1837","article-title":"Effect of PD98059 on chemotherapy in patients with colorectal cancer through ERK1\/2 pathway","volume":"24","author":"Li","year":"2019","journal-title":"J. BUON"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Tian, P., Zhu, Y., Zhang, C., Guo, X., Zhang, P., and Xue, H. (2018). Ras-ERK1\/2 signaling contributes to the development of colorectal cancer via regulating H3K9ac. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-5199-3"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13046-019-1226-8","article-title":"Inhibition of ERK1\/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis","volume":"38","author":"Yan","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.drudis.2016.06.010","article-title":"The MEK5\/ERK5 signalling pathway in cancer: A promising novel therapeutic target","volume":"21","author":"Rodrigues","year":"2016","journal-title":"Drug Discov. Today"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Stecca, B., and Rovida, E. (2019). Impact of ERK5 on the hallmarks of cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061426"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jsb.2011.09.006","article-title":"UCSF Chimera, MODELLER, and IMP: An integrated modeling system","volume":"179","author":"Yang","year":"2012","journal-title":"J. Struct. Biol."},{"key":"ref_51","first-page":"5.6.1","article-title":"Comparative protein structure modeling using MODELLER","volume":"2016","author":"Webb","year":"2016","journal-title":"Curr. Protoc. Bioinforma."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3847\/1538-3881\/ab2634","article-title":"Marvin: A Tool Kit for Streamlined Access and Visualization of the SDSS-IV MaNGA Data Set","volume":"158","author":"Cherinka","year":"2019","journal-title":"Astron. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: An advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Cheminform."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/jcc.21600","article-title":"Software News and Updates Gabedit\u2014A Graphical User Interface for Computational Chemistry Softwares","volume":"32","author":"Allouche","year":"2012","journal-title":"J. Comput. Chem."},{"key":"ref_55","unstructured":"Case, D.A., Walker, R.C., Cheatham, T.E., Simmerling, C., Roitberg, A., Merz, K.M., Luo, R., and Darden, T. (2018). Amber 18, University of California."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1021\/ci500161d","article-title":"OriginPro 9.1: Scientific data analysis and graphing software\u2014Software review","volume":"54","author":"Seifert","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models","volume":"33","author":"Kollman","year":"2000","journal-title":"Acc. Chem. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"20993","DOI":"10.1074\/jbc.M604208200","article-title":"Global gene expression analysis of ERK5 and ERK1\/2 signaling reveals a role for HIF-1 in ERK5-mediated responses","volume":"281","author":"Schweppe","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.bpj.2009.08.031","article-title":"Multiple molecular dynamics simulations of TEM \u03b2-lactamase: Dynamics and water binding of the \u03a9-loop","volume":"97","author":"Pleiss","year":"2009","journal-title":"Biophys. J."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Sousa Da Silva, A.W., and Vranken, W.F. (2012). ACPYPE\u2014AnteChamber PYthon Parser interface. BMC Res. Notes, 5.","DOI":"10.1186\/1756-0500-5-367"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Fatunde, O.A., and Brown, S.A. (2020). The role of CYP450 drug metabolism in precision Cardio-Oncology. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020604"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kiani, Y.S., Ranaghan, K.E., Jabeen, I., and Mulholland, A.J. (2019). Molecular dynamics simulation framework to probe the binding hypothesis of CYP3A4 inhibitors. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184468"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Kond\u017ea, M., Boji\u0107, M., Tomi\u0107, I., Male\u0161, \u017d., Rezi\u0107, V., and \u0106avar, I. (2021). Characterization of the cyp3a4 enzyme inhibition potential of selected flavonoids. Molecules, 26.","DOI":"10.3390\/molecules26103018"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: A webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nchembio.1629","article-title":"A unique inhibitor binding site in ERK1\/2 is associated with slow binding kinetics","volume":"10","author":"Chaikuad","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Kopczynski, M., Rumienczyk, I., Kulecka, M., Statkiewicz, M., Pysniak, K., Sandowska-Markiewicz, Z., Wojcik-Trechcinska, U., Goryca, K., Pyziak, K., and Majewska, E. (2021). Selective extracellular signal-regulated kinase 1\/2 (ERK1\/2) inhibition by the SCH772984 compound attenuates in vitro and in vivo inflammatory responses and prolongs survival in murine sepsis models. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910204"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"227","DOI":"10.15283\/ijsc18053","article-title":"The pharmacological inhibition of ERK5 enhances apoptosis in acute myeloid leukemia cells","volume":"11","author":"Kang","year":"2018","journal-title":"Int. J. Stem Cells"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/mc.23047","article-title":"Targeting ERK beyond the boundaries of the kinase active site in melanoma","volume":"58","author":"Sammons","year":"2019","journal-title":"Mol. Carcinog."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/bi501101v","article-title":"Slow inhibition and conformation selective properties of extracellular signal-regulated kinase 1 and 2 inhibitors","volume":"54","author":"Rudolph","year":"2015","journal-title":"Biochemistry"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pst.426","article-title":"Guidelines for accurate EC50\/IC50 estimation","volume":"10","author":"Sebaugh","year":"2011","journal-title":"Pharm. Stat."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1039\/b807444e","article-title":"Free energies for biological electron transfer from QM\/MM calculation: Method, application and critical assessment","volume":"10","author":"Blumberger","year":"2008","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.biophys.36.040306.132550","article-title":"Calculation of protein-ligand binding affinities","volume":"36","author":"Gilson","year":"2007","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1273\/cbij.10.1","article-title":"In silico based ligand design and docking studies of GSK-3\u03b2 inhibitors","volume":"10","author":"Babu","year":"2010","journal-title":"Chem-Bio Inform. J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.2042-7158.2010.01236.x","article-title":"Dual inhibition: A novel promising pharmacological approach for different disease conditions","volume":"63","author":"Patyar","year":"2011","journal-title":"J. Pharm. Pharmacol."}],"container-title":["Computation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-3197\/12\/3\/45\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:07:53Z","timestamp":1760105273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-3197\/12\/3\/45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":80,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["computation12030045"],"URL":"https:\/\/doi.org\/10.3390\/computation12030045","relation":{},"ISSN":["2079-3197"],"issn-type":[{"type":"electronic","value":"2079-3197"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}